Quantifying c-di-GMP and DEA NONOate

c-di-GMP and diethylamine
(DEA) NONOate were
purchased from Cayman Chemical (Ann Arbor, MI). GMP and pGpG were
purchased from Sigma-Aldrich (St. Louis, MO) and BIOLOG Life Science
Institute (Bremen, Germany), respectively. All other chemicals were
acquired from Kanto Chemical (Tokyo, Japan), Nacalai Tesque (Kyoto,
Japan), or FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan),
were of the highest guaranteed grade available, and were used without
further purification.

Free full text: Click here

Kitanishi K., Aoyama N, & Shimonaka M. (2024). Gas-Selective Catalytic Regulation by a Newly Identified Globin-Coupled Sensor Phosphodiesterase Containing an HD-GYP Domain from the Human Pathogen Vibrio fluvialis. Biochemistry, 63(4), 523-532.

Publication 2024

Corresponding Organization : Tokyo University of Science

Top 5 similar protocols

Variable analysis

independent variables

C-di-GMP
Diethylamine (DEA) NONOate

dependent variables

Not explicitly mentioned

control variables

All other chemicals acquired from Kanto Chemical, Nacalai Tesque, or FUJIFILM Wako Pure Chemical Corporation, of the highest guaranteed grade available, and used without further purification

positive controls

Not explicitly mentioned

negative controls

Not explicitly mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!